Millioni Chhabra, a scientist working on finding cure for HIV in North Carolina USA

Investors Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

First quarter 2018 results announcement

Emma Walmsley, Simon Dingemans and Luke Miels

On Wednesday 25 April we will announce our first quarter results for the period ended 31 March 2018.

Following the announcement there will be an audio webcast, including a Q&A session, hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer and Luke Miels, President, Global Pharmaceuticals.

Register to join the webcast

Latest information

GSK reaches agreement with Novartis to acquire full ownership of Consumer Healthcare Business

On Tuesday 27 March, we announced that GSK has reached an agreement with Novartis to buyout Novartis’s 36.5% stake in the Consumer Healthcare Joint Venture for $13 billion (£9.2 billion).

The press release is available here and materials from a call for investors and analysts are available below.